Clinical Trials Directory

Trials / Completed

CompletedNCT04387955

Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID)

Analysis of Chilblains Profile During COVID-19 Epidemic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

Cases of chilblains have been reported with an unusual frequency in France in the context of the COronaVirus Infectious Disease 2019 (COVID-19) epidemic. Some of these cases have been linked to a virological status in favour of a recent Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. Chilblains are acral inflammatory lesion typically reactive to cold (primary form). There are secondary forms acquired during autoimmune connectivitis such as lupus chilblain or hereditary forms related to type I Interferonopathy. An interferon type I signature has been described in these secondary forms of frostbite but also during the cytokine storm of severe forms of CoV-2 SARS infection. If cases of frostbite are indeed secondary to an SARS-CoV-2 infection, comparative analysis of their immunopathological profiles could provide a better understanding of the inflammatory mechanisms during COVID-19.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiological Sample Collection* Diagnostic test : biological sample collection at Day 0 * Two skin biopsies on chilblain at Day 0 (one biopsy for histological analysis, one biopsy for basic research) * Anal swabbing at Day 0 * Blood test at Day 0 * Blood test at Month 1 * Blood test at Month 2

Timeline

Start date
2020-04-30
Primary completion
2021-07-30
Completion
2021-07-30
First posted
2020-05-14
Last updated
2021-11-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04387955. Inclusion in this directory is not an endorsement.